Search clinical trials for: CP- 690 550

Total 11729 results

Clavis Pharma

Completed

A Study of CP-4126 in Patients With Advanced Pancreatic Cancer

Advanced Adenocarcinoma of Pancreas

Norway, Belgium
Tongji Hospital

Recruiting

Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

Remimazolam | Awake Endotracheal Intubation

China
Hoffmann-La Roche
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis

Moderate to Severe Ulcerative Colitis

United States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
Michigan State University
PriCara, Unit of Ortho-McNeil, Inc.

Completed

Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli

Healthy Volunteers

United States
Nearmedic Plus LLC

Completed

Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169

Healthy Subjects

Russian Federation
ISPA - Instituto Universitario de Ciencias Psicologicas...

Unknown

COping With PAin Through Hypnosis, Mindfulness and Spirituality (COPAHS)

Pain, Acute

Portugal
Labopharm Inc.

Completed

A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers

Healthy

United Kingdom
Ocera Therapeutics

Terminated

Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

Gastroesophageal Reflux Disease (GERD)

United States
Pfizer

Terminated

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Sarcoma | Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Colorectal Neoplasms

United States, Finland, Canada, Germany
Pfizer

Completed

Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety

Obesity

United States
Alkahest, Inc.

Completed

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

End-Stage Renal Disease

United States
POLYSAN Scientific & Technological Pharmaceutical...

Completed

"Unifuzol®" in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Russian Federation
Carsten Müller-Tidow
German Federal Ministry of Education and Research; Institut für Klinische Transfusionsmedizin...

Recruiting

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19 (RECOVER)

SARS-CoV-2 Infection

Germany
Lehigh University
National Institute on Drug Abuse (NIDA); University of Kansas Medical Center

Recruiting

Telephone All Nations Breath of Life (tANBL)

Smoking Cessation

United States
Abiomed Inc.

Recruiting

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (DTU-STEMI)

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

United States, Italy, Canada, Germany, Switzerland, Netherlands
Pfizer

Withdrawn

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Human Immunodeficiency Virus
AstraZeneca

Completed

Study of CP-675,206 in Refractory Melanoma

Refractory Melanoma

United States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
AstraZeneca

Terminated

A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma

Melanoma

United States
Universidad Católica San Antonio de Murcia

Completed

Efficacy of Different Types of Milk in Improving Sleep Quality in Subjects With Sleep Problems (Milca) (Milca)

Poor Quality Sleep

Spain
GlaxoSmithKline
Parexel

Completed

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. (AUSTRI)

Asthma

United States, Australia, Poland, Russian Federation, Spain, Ukraine, Germany, Bulgaria, Argentina, Peru, South Africa, Taiwan, Belgium, Italy, Hungary, Korea, Republic of, Austria, Romania, Colombia, Slovakia, United Kingdom, Mexico and more
University Hospital, Lille
Biotest

Recruiting

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. (CMV-GVHD)

Cytomegalovirus Infections

France
Azienda Ospedaliera Universitaria Senese
MedImmune LLC

Unknown

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Malignant Mesothelioma

Italy
Northwestern University
National Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer Foundation

Completed

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative

United States
VA Office of Research and Development
VA Connecticut Healthcare System; North Texas Veterans Healthcare System

Not yet recruiting

Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain (VACT-CP)

Chronic Pain

United States
Wake Forest University Health Sciences
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain) (CARE-CP)

Chest Pain

United States
Assistance Publique Hopitaux De Marseille

Recruiting

Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial (ULYSS)

Cardiogenic Shock

France
Jonsson Comprehensive Cancer Center
Pfizer

Completed

Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma

Melanoma (Skin)

United States
St. Jude Children's Research Hospital
Arog Pharmaceuticals, Inc.; The V Foundation for Cancer Research

Completed

PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

Diffuse Intrinsic Pontine Glioma | Progressive or Refractory High-Grade Glioma

United States
Pfizer

Completed

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

Colorectal Neoplasm

Spain, United Kingdom, United States
Azienda Ospedaliera Universitaria Senese

Unknown

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Malignant Mesothelioma

Italy
Clinica Universidad de Navarra, Universidad de...
Pfizer

Completed

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatitis C Virus Chronic Infection

Spain
Pfizer

Completed

A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy

Lung Neoplasms

United States
Abiomed Inc.

Recruiting

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Cardiogenic Shock | High Risk PCI

United States
Pfizer

Active, not recruiting

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

United States, Spain, Belgium, Canada, India, Turkey, Australia, Mexico, South Africa, Germany, China, Poland, Slovakia, Israel, Hungary, Argentina, Brazil, Russian Federation, Ukraine, United Kingdom, Italy, Costa Rica
Clinical Research Center Kiel GmbH
Nofima

Completed

Glycemic Response to Two Doses of Low Sugar Apple Juice (HB-RCT2-2015)

Prediabetes

Germany
Echosens

Completed

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients

Obesity, Morbid | Liver Fibrosis

France
Duke University
National Heart, Lung, and Blood Institute (NHLBI); American Heart Association

Completed

Ketone Pharmacokinetic Study in HFrEF

Heart Failure With Reduced Ejection Fraction

United States
GlaxoSmithKline

Completed

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma (DREAM)

Asthma

United States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
Heinrich-Heine University, Duesseldorf
The Cranberry Institute

Completed

Effects of Cranberry Consumption in Vascular Function in Healthy Individuals (Cranberry)

Healthy Men

Germany
PreEmptive Meds, Pvt. Ltd
Abbott

Completed

Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels (Prelip)

Hyperlipidemia

India
Pfizer

Completed

CP-690-550 Ointment For Chronic Plaque Psoriasis

Psoriasis

United States, Canada
University of California, San Francisco
Taiho Pharmaceutical Co., Ltd.; Sirtex Medical

Completed

Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

Rectal Cancer | Colon Cancer | Liver Metastases

United States
Insmed Incorporated

Completed

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

NTM Lung Infection Due to MAC
Sanofi

Completed

ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2

Italy
Fondo Nacional de Desarrollo Científico y Tecnológico...

Completed

A Randomized Clinical Trial for Depressed Mothers at Primary Care Level (DMH)

Depression

Chile
Sanofi

Terminated

Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition

Diabetes Mellitus, Type 2

Brazil
Dong-A University

Completed

Clopidogrel And Ticagrelor in Healthy Subjects

Pharmacodynamics

Korea, Republic of
IRCCS Fondazione Stella Maris

Completed

Quality of Life in Children With Cerebral Palsy

Unilateral and Bilateral Cerebral Palsy

Italy
National Institute of Allergy and Infectious Diseases...

Terminated

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age (LID)

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States

Search clinical trials for: CP- 690 550

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations